전체상품목록 바로가기

본문 바로가기


  • sbbn09033  
  • Rheumatology 2-Volume Set 8e

    (해외배송 가능상품)
    공급사 바로가기
    기본 정보
    도서명: Rheumatology 2-Volume Set 8e
    정   가: 620,000원
    판매가: 550,000원
    적립금: 16,500원 (3%)
    저   자: Marc C. Hochberg
    출판사: Elsevier
    ISBN  : 9780702081330
    출판일: 2022.10
    판   형: Hardcover
    수량: 수량증가수량감소
    판   수: 8e
    면   수: 2048 page
    배송방법: 택배
    배송비: 2,500원 (30,000원 이상 구매 시 무료)
    구매안내: 네이버페이로 구매할 수 없는 상품입니다.
    무이자할부 안내
    구매방법

    배송주기

    개인결제창을 통한 결제 시 네이버 마일리지 적립 및 사용이 가능합니다.

    수량
    증가 감소
    상품 옵션
    옵션선택

    (최소주문수량 1개 이상 / 최대주문수량 0개 이하)

    사이즈 가이드

    수량을 선택해주세요.

    위 옵션선택 박스를 선택하시면 아래에 상품이 추가됩니다.

    상품 목록
    상품명 상품수 가격
    Rheumatology 2-Volume Set 8e 수량증가 수량감소 (  16500)
    총 상품금액(수량) : 0 (0개)

    할인가가 적용된 최종 결제예정금액은 주문 시 확인할 수 있습니다.

    이벤트

    상품상세정보

    의학서적전문 "성보의학서적"의 신간도서입니다.

    


    Covering both the scientific basis of rheumatology and practical, clinical information for rheumatologists and trainees, Rheumatology, 8th Edition, remains a leading text in this fast-changing field. Dr. Marc Hochberg and his team of worldwide editors and authors keep you abreast of recent advances in the field— all in a user-friendly, accessible manner. Fully updated from cover to cover, this two-volume text is designed to meet the needs of all practicing and academic rheumatologists as well as arthritis-related health care professionals and scientists interested in rheumatic and musculoskeletal diseases.

    Key Features


    Covers the epidemiology, pathogenesis, clinical manifestations, therapeutic approach, and management of all major as well as rarely encountered rheumatic and musculoskeletal diseases.

    Discusses clinical examination, imaging principles, differential diagnosis, established and novel therapies, perioperative evaluation, pain management, basic science, and genetics of rheumatic and musculoskeletal diseases.  

    Uses a consistent, logical, reader-friendly format with templated chapters, concise text, and large-scale, state-of-the-art illustrations for efficient visual reference.

    Contains new chapters covering pre-clinical disease and how to address these patients, common comorbidities in rheumatoid arthritis; emerging therapies for systemic sclerosis; immune mediated complications of checkpoint inhibitors; the epidemiology of COVID-19 and rheumatic and musculoskeletal diseases, emerging treatments for osteoarthritis, and big data analytics.

    Provides updates to key topics such as systems biology and its impact on our understanding of the pathogenesis of rheumatic and musculoskeletal diseases, the microbiome in rheumatic musculoskeletal diseases, how to manage chronic pain in the patient with a rheumatic disease, drugs and reproductive health, and emerging therapies for patients with RA, SLE, spondyloarthritis, inflammatory muscle disease, and vasculitis.

    Shares the knowledge and expertise of numerous new contributing authors, as well as new co-editor Dr. Désirée van der Heijde, who is an expert in psoriatic arthritis, spondyloarthritis, imaging, and clinical epidemiology.

    Provides access to concise videos depicting the use of ultrasound for diagnosis and treatment.

    Enhanced eBook version included with purchase. Your enhanced eBook allows you to access all of the text, figures, and references from the book on a variety of devices.


    Author Information


    Edited by Marc C. Hochberg, MD, MPH, MACP, Professor of Medicine and Epidemiology and Public Health; Head, Division of Rheumatology and Clinical Immunology, University of Maryland School of Medicine, Baltimore, Maryland, USA ; Josef S. Smolen, MD, FRCP, Professor of Medicine, Chairman, Department of Medicine III, Division of Rheumatology, Medical University of Vienna;Chairman, Second Department of Medicine, Center for Rheumatic Diseases, Hietzing Hospital, Vienna, Austria ; Michael E. Weinblatt, MD, John R. and Eileen K. Riedman Professor of Medicine, Harvard Medical School; R. Bruce and Joan M. Mickey Distinguished Chair in Rheumatology, Division of Rheumatology, Immunology and Allergy, Brigham and Women’s Hospital, Boston, Massachusetts, USA ; Michael H. Weisman, MD, Cedars-Sinai Chair in Rheumatology, Director, Division of Rheumatology, Professor of Medicine, Cedars-Sinai Medical Center, David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, California, USA ; Ellen M Gravallese, MD, Professor of Medicine, University of Massachusetts Medical School, Division of Rheumatology; Director of Translational Research, Musculoskeletal Center of Excellence, University of Massachusetts Medical School and University of Massachusetts Memorial Medical Center; Myles J. McDonough Chair in Rheumatology, University of Massachusetts Medical School, Worcester, Massachusetts and Desiree van der Heijde, Professor of Rheumatology; University Hospital Maastricht; Maastricht, Netherlands



    -도서목차-



    Section 1: The Scientific Basis of Rheumatic Disease
    1. Epidemiologic concepts and the classification of rheumatic and musculoskeletal conditions

    2. Principles of clinical outcome assessment

    3. Principles of health economics and application to rheumatic disorders

    4. The synovium

    5. The articular cartilage

    6. Bone structure and function

    7. Tendons and ligaments

    8. Connective tissue responses to mechanical stresses

    9. Biomechanics of peripheral joints

    10. Biomechanics of the spine

    11. Principles of genetic epidemiology

    12. Principles and techniques in molecular biology

    13. Cytokines

    14. Signal transduction in immune cells

    15. The principles of adaptive immunity

    16. Principles of innate immunity

    17. Systems biology

    18. Epigenetics in Rheumatology

    19. The microbiome in rheumatic diseases

    20. Tissue destruction and repair

    21. Principles of tissue engineering and cell- and gene-based therapy

    22. Osteoimmunology

    23. Inflammation and its mediators

    24. Scientific basis of pain

    25. Effects of the neuroendocrine system on development and function of the immune system

    26. Interpreting the medical literature for the rheumatologist: study design and levels of evidence

    27. Ethics in clinical trials

    Section 2: Clinical Basis of Rheumatic Disease


    28. History and physical examination

    29. Pattern recognition in arthritis

    30. Role of laboratory tests in rheumatic disorders

    31. Synovial fluid analysis

    32. Minimally invasive procedures

    33. Skin in rheumatic disease

    34. The eye in rheumatic disease

    35. The heart in rheumatic disease

    36. The lung in rheumatic disease

    37. Gastrointestinal tract and rheumatic disease

    38. The kidney and rheumatic disease

    39. The nervous system in rheumatic disease

    Section 3: Evaluation: Imaging Techniques

    40. Conventional radiography and computed tomography

    41. Functional magnetic resonance imaging

    42. Musculoskeletal ultrasound

    43. Bone scintigraphy and positron emission tomography

    44. Dual x-ray absorptiometry and measurement of bone

    45. Use of imaging as an outcome measure in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis in clinical trials

    Section 4: Principles of Management

    46. Arthritis patient education, health promotion, and team approaches to management

    47. Principles of rehabilitation: physical and occupational therapy

    48a. Complementary and alternative medicine

    48b. Placebos, Caring and Healing in Rheumatology

    49. Drug Development

    50. Non-pharmacologic pain management

    51. Pharmacogenomics in rheumatology

    52. Principles of opioid treatment of chronic musculoskeletal pain

    53. Non-steroidal anti-inflammatory drugs

    54. Systemic glucocorticoids in rheumatology

    55. Nonimmunosuppresive disease-modifying antirheumatic drugs

    56. Methotrexate

    57. Leflunomide

    58. Immunosuppressives: cyclosporine, cyclophosphamide, azathioprine, mycophenolate mofetil

    59. T-cell costimulation and other directed therapies

    60. B-Cell depletion

    61. Cytokine neutralizers: interleukin-1 inhibitors

    62. Interleukin-6 Inhibition

    63. Tumor necrosis factor blocking therapies

    64. Kinase inhibition: a new therapeutic principle in rheumatology

    65. Emerging therapeutic targets: GM-CSF, IL-17and IL-23

    66. Biosimilars in Rheumatology

    67. Infections and biologic therapy in rheumatoid arthritis: an update on risk and prevention

    68. Drugs and pregnancy

    69. Aspiration and injection of joints and periarticular tissues and intralesional therapy

    70. Perioperative care of patients with rheumatic disease

    Section 5: Regional and Widespread Pain

    71. Neck pain

    72. Lumbar spine disorders

    73. The shoulder

    74. The elbow

    75. The wrist and hand

    76. The hip

    77. The knee

    78. The ankle and foot

    79. The temporomandibular joint

    80. Fibromyalgia and related syndrome

    81. Entrapment neuropathies and compartment syndromes

    82. Complex regional pain syndrome (reflex sympathetic dystrophy)

    Section 6: Rheumatoid Arthritis and Other Synovial Disorders

    83. Classification and epidemiology of rheumatoid arthritis

    84. Preclinical features of rheumatoid arthritis

    85. Clinical features of rheumatoid arthritis

    86. Extra-articular features of rheumatoid arthritis and systemic involvement

    87. Adult-onset Still's disease

    88. Imaging of rheumatoid arthritis

    89. The contribution of genetic factors to rheumatoid arthritis

    90. Animal models of arthritis

    91. Autoantibodies in rheumatoid arthritis

    92. Cellular immunity in rheumatoid arthritis

    93. Angiogenesis and vasculogenesis in rheumatoid arthritis

    94. The rheumatoid joint: synovitis and tissue destruction

    95. Evaluation and management of early inflammatory polyarthritis

    96. Evaluation and outcomes of patients with rheumatoid arthritis

    97. Management of rheumatoid arthritis: synovitis

    98. Multidisciplinary approach to rheumatoid arthritis

    Section 7: Pediatric Rheumatology

    99a. Evaluation of musculoskeletal complaints in children: clinical evaluation

    99b. Evaluation of musculoskeletal complaints in children: non-inflammatory musculoskeletal disorders

    100. Classification and epidemiology of juvenile idiopathic arthritis

    101. Clinical Features of juvenile idiopathic arthritis

    102. Etiology and pathogenesis of juvenile idiopathic arthritis

    103. Management of juvenile idiopathic arthritis

    104. The juvenile-onset spondyloarthropathies

    105. Connective tissues diseases in children

    106. Rehabilitation and psychosocial issues in juvenile idiopathic arthritis

    Section 8: Infection-Related Rheumatic Diseases

    107. Infectious Arthritis I: bacterial arthritis

    108. Infectious Arthritis II: mycobacterium, brucella, fungal, and parasitic arthritis

    109. Lyme disease

    110. Rheumatologic aspects of viral infections

    111. Acute rheumatic fever

    112. Reactive arthritis

    Section 9: Spondyloarthropathies

    113. Classification and epidemiology of spondyloarthritis

    114. Clinical features of axial spondylarthritis

    115. Etiology, pathogenesis, and pathophysiology of ankylosing spondylitis

    116. Genetics of axial spondyloarthritis

    117. Imaging of spondyloarthritis

    118. Management of ankylosing spondylitis/axial spondyloarthritis

    119. Classification and epidemiology of psoriatic arthritis

    120. Clinical features of psoriatic arthritis

    121. Etiology and pathogenesis of psoriatic arthritis

    122. Management of psoriatic arthritis

    123. Enthesopathies

    Section 10: Connective Tissue Disorders

    124. Epidemiology and classification of systemic lupus erythematosus

    125. Preclinical features of lupus

    126. Clinical features of systemic lupus erythematosus

    127. Genetics of lupus

    128. Immunopathology of systemic lupus erythematosus

    129. Animal models of lupus

    130. Autoantibodies in systemic lupus erythematosus

    131. Pathogenesis of lupus

    132. Drug-induced lupus

    133. Assessing disease activity and outcome in systemic lupus erythematosus

    134. Management of non-renal/non-central nervous system lupus

    135. Treatment of neuropsychiatric lupus

    136. Systemic lupus erythematosus: treatment—renal involvement

    137. Systemic lupus erythematosus in the pregnant patient and neonatal lupus

    138. Sjögren syndrome

    139. Antiphospholipid syndrome: overview of pathogensis, diagnosis, and management

    140. Classification and epidemiology of scleroderma

    141. Assessing disease activity and outcome in systematic sclerosis (scleroderma)

    142. Clinical features of systemic sclerosis

    143. Etiology and pathogenesis of systemic sclerosis

    144. Management of systemic sclerosis

    145. Pulmonary management of systemic sclerosis

    146. Raynaud's phenomonen

    147. Localized scleroderma and scleroderma-like syndromes

    148. Clinical features, classification, and epidemiology of inflammatory muscle disease

    149. Inflammatory muscle disease—etiology and pathogenesis

    150. Management of inflammatory muscle disease

    151. Metabolic, drug-induced, and other non-inflammatory myopathies

    152. Overlap syndromes

    Section 11: The Vasculitides

    153. Classification and epidemiology of vasculitis

    154. Biology and immunopathogenesis of vasculitis

    155. Polyarteritis nodosa and Cogan's Syndrome

    156. Polymyalgia rheumatica and giant cell arteritis

    157. Antineutrophil cytoplasmic antibody-associated vasculitis

    158. Takayasu's arteritis

    159. Behçet's syndrome

    160. Kawasaki disease

    161. Henoch-Schönlein purpura/immunoglobulin-A vasculitis

    162. Cutaneous vasculitis and panniculitis

    163. Cryoglobulinemia

    164. Primary angiitis of the central nervous system

    Section 12: Other Systemic Illnesses

    165. Monogenic autoinflammatory diseases

    166. Sarcoidosis

    167. Relapsing polychondritis

    168. Amyloidosis

    169. Digital clubbing and hypertrophic osteoarthropathy

    170. Miscellaneous arthropathies

    Section 13: Osteoarthritis and Related Disorders

    171. Osteoarthritis: epidemiology and classification

    172. Local and systemic risk factors for incidence and progression of osteoarthritis

    173. Clinical features of osteoarthritis

    174. Animal models of osteoarthritis

    175. Pathogenesis and pathology of osteoarthritis

    176. Genetics of osteoarthritis

    177. Imaging of osteoarthritis

    178. Assessment of the patient with osteoarthritis and measurement of outcomes

    179. Preclinical osteoarthritis

    180. Assessment of imaging outcomes in osteoarthritis

    181. Management of osteoarthritis

    182. Diffuse idiopathic skeletal hyperostosis

    183. Neuropathic arthropathy

    184. Osteonecrosis

    185. Rare Osteoarthritis: ochronosis and Kashin-Beck disease

    Section 14: Crystal-Related Arthropathies

    186. Epidemiology of gout

    187. Etiology and pathogenesis of gout

    188. Clinical gout

    189. The management of gout and hyperuricemia

    190. Calcium pyrophosphate crystal-associated arthropathy

    191. Basic calcium phosphate crystal deposition disease

    192. Other crystal-related arthropathies

    Section 15: Endocrine and Hemoglobin-Related Arthritis and Storage Diseases

    193. Rheumatoid manifestations of endocrine and lipid disease

    194. Hemophilia and von Willebrand disease

    195. Joint and bone lesions in hemoglobinopathies

    196. Hemochromatosis

    Section 16: Metabolic Bone Disease

    197. Epidemiology and classification of osteoporosis

    198. Clinical features of osteoporosis

    199. Pathogenesis of osteoporosis

    200. Biochemical markers in bone disease

    201. Management of osteoporosis

    202. Glucocorticoid-induced osteoporosis

    203. Osteomalacia and rickets

    204. Primary hyperparathyroidism: rheumatologic manifestations and bone disease

    205. Renal osteodystrophy

    206. Paget disease of bone

    Section 17: Heritable Disease and Tumors of Bone and Connective Tissue

    207. Gaucher disease

    208. Mucopolysaccharidoses

    209. Heritable connective tissue disorders

    210. Hypermobility syndrome

    211. Skeletal dysplasias

    212. Bone tumors


    기타 도서와 관련된 문의사항은 고객센터(02-854-2738) 또는 저희 성보의학서적 홈페이지내 도서문의 게시판에 문의바랍니다.
    감사합니다.
    성보의학서적 "http://www.medcore.kr

    상품결제정보


    배송정보

    • 배송 방법 : 택배
    • 배송 지역 : 전국지역
    • 배송 비용 : 2,500원
    • 배송 기간 : 3일 ~ 5일
    • 배송 안내 :


    • 고객님께서 저희 성보의학서적에서 주문을 하신 주문번호가 생성이 되면 그에 따른 발송준비 및 배송절차는 다음과 같습니다

      - 일반적으로 배송기간은 입금확인일로부터 3일 이내 배송을 원칙으로 합니다. 이는 재고가 확보된 도서의 경우입니다.
      (단, 산간이나 지방 및 도서지역의 경우 약 1~2일이 더 소요될 수 있습니다.)
      - 배송의 시점은 고객님의 주문 이후 입금확인 과정을 거쳐 배송이 됩니다.
      - 주문도서의 배송 시 휴일이 포함된 경우는 24시간 순연됩니다.
      - 배송료는 회원주문, 비회원주문 모두 2,500원 입니다. (일부 도서 및 산간지역은 추가 배송비 발생)
      - 주문 금액이 30,000원 이상일 경우에는 무료로 배송해 드립니다.
      - 반품/취소.환불 시 배송비는 무료로 배송이 되었을 경우, 처음 발생한 배송비까지 소급 적용될 수 있으며,
      상품 하자로 인한 도서 교환시에는 무료로 가능합니다.
      - 성보의학서적의 기본배송방법으로 택배서비스(한진택배&우체국)를 이용합니다.


      해외원서의 경우
      - 국내에서 재고를 보유한 업체가 없는 경우 해외주문을 해야 하는 상황이 생깁니다.
      이 경우 4~5주 안에 공급이 가능하며 현지 출판사 사정에 따라 구입이 어려운 경우 2~3주 안에 공지해 드립니다.
      - 재고 유무는 주문 전 사이트 상에서 배송 안내 문구로 구분 가능하며, 필요에 따라 전화 문의 주시면 거래처를 통해
      다시 한번 국내재고를 확인해 드립니다.

      - 해외 주문 도서는 고객님의 요청에 의해 주문하는 '개인주문' 상품으로, 단순한 고객변심/착오로 인한 취소, 교환, 반품은 불가능합니다.
      - 해외주문 시 도서가격 및 수입 제반 비용 등을 모두 선결제로 진행하고 재고 관련 등의 사유로 취소, 교환, 반품이 불가능하오니
      이점 꼭 숙지하시고 해외주문시 신중하게 주문하여 주시기 바랍니다.

    교환 및 반품정보

    반품안내
    전자상거래에 의한 소비자보호에 관한 법률에 의거 반품 가능 기간내에는 반품을 요청하실 수 있습니다.

    반품가능기간
    - 단순변심 : 물품 수령 후 14일 이내 (단, 고객님의 요청으로 주문된 해외원서 제외)


    - 주문하신 것과 다른 상품을 받으신 경우

    - 파본인 상품을 받으신 경우
    - 배송과정에서 손상된 상품을 받으신 경우



    - 개봉된 DVD, CD-ROM, 카세트테이프 (단, 배송 중 파손된 상품 제외)

    - 탐독의 흔적이 있는 경우
    - 소비자의 실수로 상품이 훼손된 경우
    - 고객님의 주문으로 수입된 해외 도서인 경우
    - 수령일로 14일 지난 상품의 경우

    - 해외 주문 도서는 고객님의 요청에 의해 주문하는 '개인주문' 상품으로, 단순한 고객변심/착오로 인한 취소, 교환, 반품은 불가능합니다.
    - 해외주문 시 도서가격 및 수입 제반 비용 등을 모두 선결제로 진행하고 재고 관련 등의 사유로 취소, 교환, 반품이 불가능하오니
      이점 꼭 숙지하시고 해외주문시 신중하게 주문하여 주시기 바랍니다.


    반품절차
    - 배송완료후 3일 이내에 고객센터 02-854-2738 혹은 1:1 문의게시판을 통해 교환 및 반품 의사를 알려주세요.
    - 도서는 택배 또는 등기우편으로 보내주시기 바랍니다.
    - 14일 이내에 교환/반품/환불 받으실 상품이 회수되어야 하며, 반품과 환불의 경우 상품주문시 면제받으셨던
      배송비와 반품배송비까지 고객님께서 부담하시게 됩니다.

    반품주소
    (10881) 서울시 구로구 구로중앙로26길 32(구로동) 1층(성보의학서적)
    전화) 02-854-2738

    환불방법
    - 대금은 반품 확인 후에, 카드취소/ 적립금 지급/ 계좌로 환불조치 해 드립니다.
    - 카드결제 시 카드 승인취소절차를 밟게 되며 무통장입금시 현금 환불 혹은 적립금으로 변환 가능합니다.
    - 반품도서와 함께 도서명, 주문번호와 환불계좌번호를 알려주시면 빠른 처리 가능합니다.



    서비스문의


    고객센터: (02)854-2738

    상품사용후기

    상품의 사용후기를 적어주세요.

    게시물이 없습니다

    상품문의하기 모두 보기

    상품 Q&A

    상품에 대해 궁금한 점을 해결해 드립니다.

    게시물이 없습니다

    상품문의하기 모두 보기

  • sbbn09036  


  • 장바구니 0

    맨위로

    마이쇼핑 게시판 배송조회 blog